Nicotinamide (INN,BANUK[2]) orniacinamide (USANUS) is a form ofvitamin B3 found in food and used as adietary supplement and medication.[3][4][5] As a supplement, it is usedorally (swallowed by mouth) to prevent and treatpellagra (niacin deficiency).[4] This is not to be confused with Niacin. While both are very similar both have different behaviors on the body. Whilenicotinic acid (niacin) may be used for this purpose, nicotinamide has the benefit of not causingskin flushing.[4] As a cream, it is used to treatacne, and has been observed in clinical studies to improve the appearance of aging skin by reducinghyperpigmentation and redness.[5][6] It is awater-soluble vitamin.
Clinical trials have show promise in eye health, in this B3 form, it has shown promise in protecting eye health, particularly in the context of glaucoma. It is believed to support the health of retinal ganglion cells and may help protect against the damage caused by glaucoma. Nicotinamide has been studied for its potential neuroprotective effects, and while some clinical trials have demonstrated improvements in visual fields and retinal function, it is not yet approved for the treatment of glaucoma. The use of nicotinamide should be approached with caution, especially at high doses, due to the risk of liver injury. Ongoing research continues to explore the full potential of nicotinamide in eye protection and its role in managing eye conditions.[7]
Nicotinamidecream is used as a treatment foracne.[5] It has anti-inflammatory actions, which may benefit people with inflammatory skin conditions.[20]
Nicotinamide increases the biosynthesis ofceramides in humankeratinocytes in vitro and improves the epidermal permeability barrier in vivo.[21] The application of 2% topical nicotinamide for 2 and 4 weeks is effective in lowering thesebum excretion rate.[22] Nicotinamide has been shown to preventCutibacterium acnes-induced activation oftoll-like receptor 2, which ultimately results in the down-regulation of pro-inflammatoryinterleukin-8 production.[23]
Nicotinamide, also known as niacinamide, is a form of vitamin B3 that has shown promise in protecting eye health, particularly in the context ofGlaucoma.[25]
Nicotinamide has minimal side effects.[8][9] At very high doses above 3 g per day acuteliver toxicity has been documented in at least one case.[8] Normal doses are safe duringpregnancy.[10]
NAD+ acts as an electron carrier that mediates the interconversion of energy between nutrients and the cell's energy currency,adenosine triphosphate (ATP). In oxidation-reduction reactions, the active part of the cofactor is the nicotinamide. In NAD+, the nitrogen in the aromatic nicotinamide ring is covalently bonded to adenine dinucleotide. The shared electrons of the other carbon atoms in the aromatic ring stabilize the formal charge on the nitrogen. When a hydride atom is added onto NAD+ to form NADH, the molecule loses its aromaticity and therefore a good amount of stability. This higher energy product later releases its energy with the release of a hydride, and in the case of the electron transport chain, it assists in formingadenosine triphosphate.[37]
When one mole of NADH is oxidized, 158.2kJ of energy will be released.[37]
Nicotinamide occurs as a component of a variety of biological systems, including within thevitamin B family and specifically thevitamin B3 complex.[11][12] It is also a critically important part of the structures ofNADH and NAD+, where theN-substituted aromatic ring in the oxidised NAD+ form undergoes reduction with hydride attack to form NADH.[35] TheNADPH/NADP+ structures have the same ring, and are involved in similar biochemical reactions.
Nicotinamide can be methylated in the liver to biologically inactive1-Methylnicotinamide when there are sufficient methyl donors.
Nicotinamide occurs in trace amounts mainly in meat, fish, nuts, and mushrooms, as well as to a lesser extent in some vegetables.[38] It is commonly added to cereals and other foods. Many multivitamins contain 20–30 mg ofvitamin B3, and it is also available in higher doses.[39]
A 2015 trial found nicotinamide to reduce the rate of new nonmelanoma skin cancers and actinic keratoses in a group of people at high risk for the conditions.[42]
Nicotinamide has been investigated for many additional disorders, including treatment ofbullous pemphigoid and nonmelanoma skin cancers.[43]
Nicotinamide may be beneficial in treating psoriasis.[44]
There is tentative evidence for a potential role of nicotinamide in treating acne, rosacea, autoimmune blistering disorders, ageing skin, and atopic dermatitis.[43] Nicotinamide also inhibits poly(ADP-ribose)polymerases (PARP-1), enzymes involved in the rejoining of DNA strand breaks induced by radiation or chemotherapy.[45] ARCON (accelerated radiotherapy plus carbogen inhalation and nicotinamide) has been studied in cancer.[46]
Research has suggested nicotinamide may play a role in the treatment ofHIV.[47]
^Bissett DL, Oblong JE, Berge CA (July 2005). "Niacinamide: A B vitamin that improves aging facial skin appearance".Dermatologic Surgery.31 (7 Pt 2):860–5, discussion 865.doi:10.1111/j.1524-4725.2005.31732.PMID16029679.
^World Health Organization (2019).World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization.hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^World Health Organization (2021).World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization.hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
^Niren NM (January 2006). "Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review".Cutis.77 (1 Suppl):11–6.PMID16871774.
^Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S (September 2000). "Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier".The British Journal of Dermatology.143 (3):524–31.doi:10.1111/j.1365-2133.2000.03705.x.PMID10971324.S2CID21874670.
^Rolfe HM (December 2014). "A review of nicotinamide: treatment of skin diseases and potential side effects".Journal of Cosmetic Dermatology.13 (4):324–8.doi:10.1111/jocd.12119.PMID25399625.S2CID28160151.
^Ranaweera A (2017)."Nicotinamide".DermNet New Zealand (www.dermnetnz.org). DermNet New Zealand Trust.Archived from the original on 25 March 2017. Retrieved30 June 2017.
^British Pharmacopoeia Commission Secretariat (2009).Index, BP 2009(PDF). Archived fromthe original(PDF) on 22 July 2011. Retrieved4 February 2010.
^Kaanders JH, Bussink J, van der Kogel AJ (December 2002). "ARCON: a novel biology-based approach in radiotherapy".The Lancet. Oncology.3 (12):728–37.doi:10.1016/s1470-2045(02)00929-4.PMID12473514.